KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Current Taxes (2021 - 2023)

Vir Biotechnology's Current Taxes history spans 3 years, with the latest figure at $15.3 million for Q1 2023.

  • On a quarterly basis, Current Taxes fell 96.23% to $15.3 million in Q1 2023 year-over-year; TTM through Mar 2023 was $15.3 million, a 96.23% decrease, with the full-year FY2022 number at $15.2 million, up 144.94% from a year prior.
  • Current Taxes hit $15.3 million in Q1 2023 for Vir Biotechnology, roughly flat from $15.2 million in the prior quarter.
  • Over the last five years, Current Taxes for VIR hit a ceiling of $404.4 million in Q1 2022 and a floor of $6.2 million in Q4 2021.
  • Historically, Current Taxes has averaged $116.1 million across 3 years, with a median of $56.7 million in 2022.
  • Biggest five-year swings in Current Taxes: skyrocketed 144.94% in 2022 and later crashed 96.23% in 2023.
  • Tracing VIR's Current Taxes over 3 years: stood at $6.2 million in 2021, then soared by 144.94% to $15.2 million in 2022, then rose by 0.16% to $15.3 million in 2023.
  • Business Quant data shows Current Taxes for VIR at $15.3 million in Q1 2023, $15.2 million in Q4 2022, and $98.2 million in Q3 2022.